Stepan Reports First Quarter 2025 Results

Rhea-AI Summary

Stepan Company (NYSE: SCL) reported strong Q1 2025 results with net income up 42% to $19.7 million. The company achieved notable growth with global sales volume increasing 4% year-over-year and adjusted EBITDA rising 12% to $57.5 million.

Key highlights include:

• Net sales increased 8% to $593.3 million
• Surfactants segment saw 10% growth with sales of $430.3 million
• Polymers segment remained flat at $146.1 million despite 7% volume growth
• Specialty Products grew 11% to $16.8 million

The company's new Pasadena, Texas facility is now operational, supporting specialty alkoxylation business growth. CEO Luis E. Rojo expressed optimism about continued earnings improvement, citing double-digit volume growth in Agricultural and Oilfield markets. Despite negative free cash flow of $25.8 million due to higher working capital requirements, management remains confident about delivering full-year adjusted EBITDA growth and positive free cash flow in 2025.

Positive

• Net income increased 42% to $19.7M vs prior year
• Global sales volume up 4% year-over-year
• Adjusted EBITDA grew 12% to $57.5M
• Double-digit volume growth in Agricultural and Oilfield end markets
• New Pasadena, Texas facility now operational for specialty alkoxylation business
• Surfactant sales increased 10% to $430.3M
• Polymer volume grew 7% during the quarter
• Effective tax rate decreased to 20.1% from 28.6%

Negative

• Negative free cash flow of $25.8M due to higher working capital requirements
• Polymer operating income decreased 4% vs prior year
• Foreign currency translation negatively impacted sales by 3-5%
• Polymer selling prices decreased 7% due to lower raw material costs and competitive pressures
• High cost inventory carryover affecting Polymer segment performance

Insights

Financial Analyst

Stepan delivered strong Q1 results with net income up 42%, driven by Surfactants and Specialty Products despite temporary negative free cash flow.

Stepan Company's Q1 2025 results demonstrate substantial financial improvement across key metrics. The reported net income of $19.7 million represents a 42% year-over-year increase, while adjusted net income reached $19.3 million, up 32%. This translated to diluted EPS of $0.86, a 41% improvement.

Revenue grew 8% to $593.3 million, driven by a 4% increase in global sales volume and higher selling prices, partially offset by negative foreign currency translation. The company's operational performance was impressive, with EBITDA of $58.0 million (up 16%) and adjusted EBITDA of $57.5 million (up 12%).

Segment performance reveals the growth drivers: Surfactants delivered strong results with 10% higher sales and 11% increased operating income, benefiting from double-digit growth in Agricultural and Oilfield end markets. Specialty Products excelled with 11% sales growth and 29% higher operating income. However, Polymers showed mixed results with flat sales and a 4% decline in operating income despite 7% volume growth, hampered by less favorable product mix and high-cost inventory.

The quarter's negative free cash flow of $25.8 million warrants attention. This resulted from higher working capital investments to support business growth and prepare for potential tariff impacts. This appears to be a strategic investment rather than an operational weakness, though the efficiency of this capital deployment will be important to monitor.

A significant tax rate reduction to 20.1% from 28.6% last year, driven by a tax audit settlement, provided additional earnings support. The newly operational Pasadena, Texas facility represents a strategic asset expected to drive volume growth and supply chain savings in the second half of 2025.

Management's outlook remains cautiously optimistic, with expectations for full-year adjusted EBITDA and net income growth despite market uncertainties including potential tariff impacts. The strong start to 2025 with broad-based volume growth positions Stepan well to execute its business strategies focused on improved execution and accelerated free cash flow generation.

NORTHBROOK, Ill., April 29, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported:

First Quarter 2025 Highlights

• Reported net income was $19.7 million, up 42% versus the prior year. Adjusted net income⁽¹⁾ was $19.3 million, up 32% versus the prior year.
• EBITDA⁽²⁾ was $58.0 million and Adjusted EBITDA⁽²⁾ was $57.5 million, up 16% and 12% respectively, year-over-year.
• Global sales volume was up 4% year-over-year.
• Cash from Operations was $6.9 million during the quarter. Free cash flow⁽³⁾ for the quarter was a negative $25.8 million driven by higher working capital to support business growth and in anticipation of tariffs.

"I am encouraged by the earnings and volume growth we delivered in the first quarter.  Volume growth was broad-based as Surfactants, Polymers and the Specialty Products MCT business were all up," said Luis E. Rojo, President and Chief Executive Officer.  "First quarter adjusted EBITDA grew double digits driven by the Surfactant and Specialty Product businesses.  In Surfactants, we continued to experience double-digit volume growth within the Agricultural and Oilfield end markets and with our Distribution partners.  We are encouraged by this growth within several of our key strategic end markets.  Polymer volume was up 7% during the quarter. North American and European Rigid Polyol, Specialty Polyols and Phthalic Anhydride all delivered volume growth during the quarter.  Free cash flow was negative due to typically higher working capital requirements in the first quarter.  Our new Pasadena, Texas site, which will support the growth of our specialty alkoxylation business, is now operational.  We are pleased with the start of 2025 and remain focused on continued earnings improvement."

Financial Summary

		Three Months Ended March 31,
($ in thousands, except per share data)		2025				2024				% Change
Net Sales		$	593,255			$	551,418				8	%
Operating Income		$	28,288			$	20,169				40	%
Net Income		$	19,711			$	13,893				42	%
Earnings per Diluted Share		$	0.86			$	0.61				41	%
Adjusted Net Income *		$	19,310			$	14,656				32	%
Adjusted Earnings per    Diluted Share *		$	0.84			$	0.64				31	%

* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

Percentage Change in Net Sales

Net sales in the first quarter of 2025 increased 8% year-over-year.  This increase reflects a 4% increase in sales volume and higher selling prices that were partially offset by the negative impact of foreign currency translation. 

		Three Months Ended March 31, 2025
Volume			4	%
Selling Price & Mix			7	%
Foreign Translation			(3)	%
Total			8	%

Segment Results

		Three Months Ended March 31,
($ in thousands)		2025				2024				% Change
Net Sales
Surfactants		$	430,337			$	390,820				10	%
Polymers		$	146,116			$	145,508				0	%
Specialty Products		$	16,802			$	15,090				11	%
Total Net Sales		$	593,255			$	551,418				8	%

 

		Three Months Ended March 31,
($ in thousands, all amounts pre-tax)		2025				2024				% Change
Operating Income
Surfactants		$	28,930			$	26,079				11	%
Polymers		$	8,018			$	8,382				(4)	%
Specialty Products		$	5,508			$	4,268				29	%
Total Segment    Operating Income		$	42,456			$	38,729				10	%
Corporate Expenses		$	(14,168)			$	(18,560)				(24)	%
Consolidated    Operating Income		$	28,288			$	20,169				40	%

 

		Three Months Ended March 31,
($ in millions)		2025				2024				% Change
EBITDA		$	58.0			$	50.2				16	%
Adjusted EBITDA
Surfactants		$	48.3			$	43.8				10	%
Polymers		$	16.1			$	16.4				(2)	%
Specialty Products		$	7.0			$	5.8				21	%
Unallocated Corporate		$	(13.9)			$	(14.8)				(6)	%
Consolidated Adjusted EBITDA		$	57.5			$	51.2				12	%

Consolidated operating income in the quarter increased $8.1 million, or 40%, year-over-year.  Consolidated adjusted EBITDA⁽²⁾ increased $6.3 million, or 12%, year-over-year driven by improved Surfactant product/customer mix, sales volume growth and the non-recurrence of prior year operational interruptions at the Millsdale plant site. Despite 7% volume growth, Polymer EBITDA was down slightly due to less favorable product mix and high cost inventory carryover.     

• Surfactant net sales were $430.3 million for the quarter, a 10% increase versus the prior year. Selling prices were up 12% primarily due to improved product and customer mix and the pass through of higher raw material costs. Sales volume was up 3% year-over-year primarily due to double digit growth within the Agricultural and Oilfield end markets along with our distribution partners. This growth was partially offset by lower demand within the commodity Consumer Products end markets. Foreign currency translation negatively impacted net sales by 5%. Surfactant operating income for the quarter increased $2.9 million, or 11%, versus the prior year. Surfactant adjusted EBITDA⁽²⁾ increased $4.5 million, or 10%, versus the prior year. This increase was primarily driven by the 3% growth in sales volume, improved product/customer mix and the non-recurrence of prior year operational interruptions at the Millsdale plant site.
  
  
• Polymer net sales were $146.1 million for the quarter, flat versus the prior year. Selling prices decreased 7%, primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume increased 7% in the quarter. North American and European Rigid Polyol, Specialty Polyols and commodity Phthalic Anhydride sales volume was up year-over-year. Foreign currency translation had a nominal impact on net sales during the quarter. Polymer operating income decreased $0.4 million, or 4%, versus the prior year. Polymer adjusted EBITDA⁽²⁾ decreased $0.3 million, or 2%, versus the prior year primarily due to less favorable product mix and high cost inventory carryover.
  
  
• Specialty Product net sales were $16.8 million for the quarter, an 11% increase versus the prior year, primarily due to higher selling prices. Specialty Product operating income increased $1.2 million, or 29%, versus the prior year. Specialty Product adjusted EBITDA⁽²⁾ increased $1.2 million, or 21%. The increase in adjusted EBITDA⁽²⁾ was primarily due to margin recovery within the medium chain triglycerides product line.

Income Taxes

The Company's effective tax rate was 20.1% in the first quarter of 2025 versus 28.6% in the first quarter of 2024.  This decrease was primarily attributable to favorable discrete items associated with a tax audit settlement.   

Outlook

"Looking forward, we remain focused on accelerating our business strategies through improved execution to grow volume, improve product and customer mix and accelerate free cash flow generation.  We believe our Surfactant business will experience continued growth in our key strategic end markets and that Polymer demand will continue improving as we get more market certainty and we execute our innovation and growth plans.  Our Pasadena facility is now operational, and as we have previously communicated, this should enable us to deliver volume growth and Supply Chain savings during the second half of the year,"  said Luis E. Rojo, President and Chief Executive Officer.  "Despite all the current market uncertainties, including the impact of tariffs, we remain cautiously optimistic that we will deliver full year Adjusted EBITDA and Adjusted Net Income growth and positive free cash flow in 2025."

Notes

(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

(2) EBITDA and adjusted EBITDA are non-GAAP measures.  See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.

(3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures.  Cash generated from operations was $6.9 million during the first quarter of 2025 and capital expenditures were $32.7 million. 

Conference Call

Stepan Company will host a conference call to discuss its second quarter results at 8:00 a.m. ET (7:00 a.m. CT) on April 29, 2025. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN.  To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time.  The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

Supporting Slides

Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to  accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, changes in global trade policies, including tariffs; legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Tables follow

Table I
STEPAN COMPANY
For the Three Months Ended March 31, 2025 and 2024
(Unaudited – in 000's, except per share data)
		Three Months Ended March 31,
		2025				2024
Net Sales		$	593,255			$	551,418
Cost of Sales			517,792				481,137
Gross Profit			75,463				70,281
Operating Expenses:
Selling			12,108				11,388
Administrative			21,414				22,690
Research, Development and Technical Services			14,649				14,256
Deferred Compensation Expense (Income)			(996)				1,778
			47,175				50,112
Operating Income			28,288				20,169
Other Income (Expense):
Interest, Net			(4,126)				(3,071)
Other, Net			502				2,362
			(3,624)				(709)
Income Before Provision for Income Taxes			24,664				19,460
Provision for Income Taxes			4,953				5,567
Net Income			19,711				13,893
Net Income Per Common Share
Basic		$	0.86			$	0.61
Diluted		$	0.86			$	0.61
Shares Used to Compute Net Income Per    Common Share
Basic			22,867				22,824
Diluted			22,890				22,948

 

Table II
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share*
		Three Months Ended March 31,
($ in thousands, except per share amounts)		2025				EPS				2024				EPS
Net Income Reported		$	19,711			$	0.86			$	13,893			$	0.61
Deferred Compensation    (Income) Expense		$	(470)			$	(0.02)			$	(388)			$	(0.02)
Environmental Remediation     Expense		$	69			$	0.00			$	1,151			$	0.05
Adjusted Net Income		$	19,310			$	0.84			$	14,656			$	0.64

* All amounts in this table are presented after-tax

The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition.  The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators.  Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years.  These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies.  The Company's Annual Report on Form 10-K for the year ended December 31, 2024 contains additional information regarding the use of non-GAAP financial measures.

Summary of First Quarter 2025 Adjusted Net Income Items

Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

• Deferred Compensation: The first quarter of 2025 reported net income includes $0.5 million of after-tax income versus $0.4 million of after-tax income in the prior year.
  
  
• Environmental Remediation: The first quarter of 2025 reported net income includes $0.1 million of after-tax expense versus $1.2 million of after-tax expense in the prior year.

 

Table III
Reconciliation of Pre-Tax to After-Tax Adjustments
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred.
		Three Months Ended March 31,
($ in thousands, except per share amounts)		2025				EPS				2024				EPS
Pre-Tax Adjustments
Deferred Compensation (Income) Expense		$	(626)							$	(517)
Environmental Remediation Expense		$	92							$	1,534
Total Pre-Tax Adjustments		$	(534)							$	1,017
Cumulative Tax Effect on Adjustments		$	133							$	(254)
After-Tax Adjustments		$	(401)			$	(0.02)			$	763			$	0.03

 

Table IV
Deferred Compensation Plans
The full effect of the deferred compensation plans on quarterly pre-tax income was $0.6 million of income versus $0.5 million of income in the prior year.  The quarter-end market prices of Company stock and the impact of deferred compensation on specific income statement line items is summarized below:
		2025				2024
		3/31				12/31				9/30				6/30				3/31
Stepan Company		$	55.04			$	64.70			$	77.25			$	83.96			$	90.04

 

		Three Months Ended March 31,
($ in thousands)		2025				2024
Deferred Compensation
Operating Income (Expense)		$	996			$	(1,778)
Other, net – Mutual Fund Gain (Loss)			(370)				2,295
Total Pre-Tax		$	626			$	517
Total After-Tax		$	470			$	388

 

Effects of Foreign Currency Translation
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period.  The table below presents the impact that foreign currency translation had on select income statement line items.
($ in millions)		Three Months Ended March 31,								Change				Change Due to Foreign Currency Translation
		2025				2024
Net Sales		$	593.3			$	551.4			$	41.9			$	(18.5)
Gross Profit			75.5				70.3			$	5.2				(2.7)
Operating Income			28.3				20.2			$	8.1				(1.8)
Pretax Income			24.7				19.5			$	5.2				(1.9)

 

Corporate Expenses
		Three Months Ended March 31,
($ in thousands)		2025				2024				% Change
Total Corporate Expenses		$	14,168			$	18,560				(24)	%
Less:
Deferred Compensation (Income) Expense		$	(996)			$	1,778				(156)	%
Environmental Remediation       Expense		$	92			$	1,534				(94)	%
Adjusted Corporate Expenses		$	15,072			$	15,248				(1)	%

Adjusted Corporate expenses decreased $0.2 million, or 1% for the quarter.

Table V
Stepan Company
Consolidated Balance Sheets
March 31, 2025 and December 31, 2024
		March 31, 2025				December 31, 2024
ASSETS
Current Assets		$	897,156			$	810,429
Property, Plant & Equipment, Net			1,202,245				1,198,454
Other Assets			290,282				295,765
Total Assets		$	2,389,683			$	2,304,648
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities		$	739,480			$	669,034
Deferred Income Taxes			9,677				9,612
Long-term Debt			330,799				332,632
Other Non-current Liabilities			109,189				123,436
Total Stepan Company Stockholders' Equity			1,200,538				1,169,934
Total Liabilities and Stockholders' Equity		$	2,389,683			$	2,304,648

 

Selected Balance Sheet Information
The Company's total debt increased by $33.9 million and cash increased by $7.8 million versus December  31, 2024.  The Company's net debt level increased $26.1 million versus December 31, 2024 and the net debt ratio remained constant at 31% in the quarter (Net Debt and Net Debt Ratio are non-GAAP measures, reconciliations of which are shown in the table below).  Management uses the non-GAAP net debt metric to show a more complete picture of the Company's overall liquidity, financial flexibility and leverage level.
($ in millions)	March 31, 2025				December 31, 2024
Net Debt
Total Debt	$	659.3			$	625.4
Cash		107.5				99.7
Net Debt	$	551.8			$	525.7
Equity		1,200.5				1,169.9
Net Debt + Equity	$	1,752.3			$	1,695.6
Net Debt / (Net Debt + Equity)		31	%			31	%

 

The major working capital components were:

($ in millions)	March 31, 2025				December 31, 2024
Net Receivables	$	436.5			$	388.0
Inventories		309.3				288.7
Accounts Payable		(298.1)				(258.8)
	$	447.7			$	417.9

 

Table VI
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income.
		Three Months Ended March 31, 2025
($ in millions)		Surfactants				Polymers				Specialty Products				Unallocated Corporate				Consolidated
Operating Income		$	28.9			$	8.0			$	5.5			$	(14.2)			$	28.2
Depreciation and Amortization		$	19.4			$	8.1			$	1.5			$	0.3			$	29.3
Other, Net Income		$	-			$	-			$	-			$	0.5			$	0.5
EBITDA																		$	58.0
Deferred Compensation		$	-			$	-			$	-			$	(0.6)			$	(0.6)
Environmental Remediation		$	-			$	-			$	-			$	0.1			$	0.1
Adjusted EBITDA		$	48.3			$	16.1			$	7.0			$	(13.9)			$	57.5
		Three Months Ended March 31, 2024
($ in millions)		Surfactants				Polymers				Specialty Products				Unallocated Corporate				Consolidated
Operating Income		$	26.1			$	8.4			$	4.3			$	(18.6)			$	20.2
Depreciation and Amortization		$	17.7			$	8.0			$	1.5			$	0.4			$	27.6
Other, Net Income		$	-			$	-			$	-			$	2.4			$	2.4
EBITDA																		$	50.2
Deferred Compensation		$	-			$	-			$	-			$	(0.5)			$	(0.5)
Environmental Remediation		$	-			$	-			$	-			$	1.5			$	1.5
Adjusted EBITDA		$	43.8			$	16.4			$	5.8			$	(14.8)			$	51.2

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-first-quarter-2025-results-302440588.html

SOURCE Stepan Company

FAQ

How much did Stepan (SCL) earnings grow in Q1 2025?

Stepan's reported net income grew 42% to $19.7 million in Q1 2025 compared to Q1 2024, with adjusted net income up 32% to $19.3 million. Earnings per diluted share increased 41% to $0.86.

What drove Stepan (SCL) revenue growth in first quarter 2025?

Stepan's 8% revenue growth in Q1 2025 was driven by a 4% increase in sales volume, higher selling prices, partially offset by negative foreign currency impact. Surfactants segment led with 10% growth, while Specialty Products grew 11%.

Why was Stepan (SCL) free cash flow negative in Q1 2025?

Stepan reported negative free cash flow of $25.8 million in Q1 2025 due to higher working capital requirements to support business growth and preparation for anticipated tariffs. Cash from operations was $6.9 million while capital expenditures were $32.7 million.

What is the outlook for Stepan (SCL) stock in 2025?

Management expects full year Adjusted EBITDA and Adjusted Net Income growth with positive free cash flow in 2025, driven by continued growth in strategic markets, improving polymer demand, and operational benefits from the new Pasadena facility in second half 2025.

How did Stepan's (SCL) different segments perform in Q1 2025?

Surfactants sales grew 10% with 3% volume growth, Polymers remained flat with 7% volume growth but lower prices, and Specialty Products increased 11%. Surfactants and Specialty Products showed strong EBITDA growth while Polymers declined slightly.